Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sequential Nano-Penetrators of Capillarized Liver Sinusoids and Extracellular Matrix Barriers for Liver Fibrosis Therapy
Lingfeng Zhang, Xinghuan Wang, Chenglu Zhang, et al.
ACS Nano (2022) Vol. 16, Iss. 9, pp. 14029-14042
Closed Access | Times Cited: 46

Showing 26-50 of 46 citing articles:

Neutrophil-Based Bionic Delivery System Breaks Through the Capillary Barrier of Liver Sinusoidal Endothelial Cells and Inhibits the Activation of Hepatic Stellate Cells
Dan Sun, Xiao Du, Xinyu Cao, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 2043-2057
Closed Access | Times Cited: 3
Extracellular vesicles targeting non-parenchymal cells: the therapeutical effect on liver fibrosis
Yingying Liu, Lin Wang
eGastroenterology (2024) Vol. 2, Iss. 1, pp. e100040-e100040
Open Access | Times Cited: 3
Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
Leonard Kaps, María J. Limeres, Paul M. Schneider, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11869-11869
Open Access | Times Cited: 7
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis
Shao‐Fang Chen, Danping Zhuang, Qingyun Jia, et al.
Biomaterials Research (2024) Vol. 28
Open Access | Times Cited: 2
Vitamin A-modified ZIF-8 lipid nanoparticles for the therapy of liver fibrosis
Si Qin, Xuening Du, Kaili Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123167-123167
Closed Access | Times Cited: 5
Angiocrine Signaling in Sinusoidal Health and Disease
Shawna A. Cooper, Enis Kostallari, Vijay H. Shah
Seminars in Liver Disease (2023) Vol. 43, Iss. 03, pp. 245-257
Open Access | Times Cited: 4
Exploring the impact of severity in hepatic fibrosis disease on the intrahepatic distribution of novel biodegradable nanoparticles targeted towards different disease biomarkers
Arunpandian Balaji, Craig A. Bell, Zachary H. Houston, et al.
Biomaterials (2023) Vol. 302, pp. 122318-122318
Open Access | Times Cited: 4
Oral delivery of ferroptosis inducers for effective treatment of hepatic fibrosis
Yinglan Yu, Shunlong Zhang, Yongfeng Xu, et al.
Nano Research (2024) Vol. 17, Iss. 8, pp. 7621-7630
Closed Access | Times Cited: 1
Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine
Pei Liu, Wanli Liang, Rui‐Ting Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Multilayer coating of a 3D-printed tracheal stent prevents tracheal stenosis
Tongtong Zhang, B. A. Zhuang, Feng Zhang, et al.
Applied Materials Today (2024) Vol. 39, pp. 102349-102349
Closed Access | Times Cited: 1
Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis
Damai Ria Setyawati, Fransiska Christydira Sekaringtyas, Riyona Desvy Pratiwi, et al.
Beilstein Journal of Nanotechnology (2024) Vol. 15, pp. 1105-1116
Open Access | Times Cited: 1
Accessing the pharmacokinetics of magnetic nanoparticles in cirrhosis-associated hepatocarcinogenesis by ordinary differential equation modeling and AC biosusceptometry
Diego Samuel Rodrigues, Guilherme Soares, V. A. González‐López, et al.
Mathematics in Medical and Life Sciences (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 1
Nanotechnology-based combinational strategies toward the regulation of myofibroblasts and diseased microenvironment in liver fibrosis and hepatic carcinoma
Fenfen Li, Ying Zhao, Guangjun Nie
Nano Research (2023) Vol. 16, Iss. 12, pp. 13042-13055
Closed Access | Times Cited: 2
RNA Nanotherapeutics with Fibrosis Overexpression and Retention (FORT) for NASH Treatment
Lei Miao, Xinzhu Shan, Zhiqiang Zhao, et al.
Research Square (Research Square) (2024)
Open Access
Nanoparticle-based delivery system for normalization of liver sinusoidal endothelial cells in hepatocellular carcinoma
Shufen Chen, Lin Jin, Zhiping Zeng, et al.
Materials & Design (2024) Vol. 245, pp. 113242-113242
Open Access
Sequential system based on ferritin delivery system and cell therapy for modulating the pathological microenvironment and promoting recovery
Lixing Xu, Jie Yang, Xinyu Cao, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124607-124607
Closed Access
Nano-encapsulation of drugs to target hepatic stellate cells: Toward precision treatments of liver fibrosis
Yue Yuan, Jiaxuan Li, Min Chen, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 318-336
Closed Access
Pathological Microenvironment‐Remodeling Nanoparticles to Alleviate Liver Fibrosis: Reversing Hepatocytes‐Hepatic Stellate Cells Malignant Crosstalk
Lingfeng Zhang, Wen‐Qi Deng, Xinghuan Wang, et al.
Advanced Science (2024)
Open Access
Spontaneous Inflammation Resolution Inspired Nanoparticles Promote Neutrophil Apoptosis and Macrophage Efferocytosis for Acute Respiratory Distress Syndrome Treatment
Yi Wang, Lingfeng Zhang, Jiaojiao Zhang, et al.
Advanced Healthcare Materials (2024)
Closed Access
The Role of Liver Sinusoidal Endothelial Cells in NAFLD Disease
玥勤 黄
Pharmacy Information (2024) Vol. 13, Iss. 03, pp. 204-214
Closed Access
Precisely Controlling the Activation of an Iron-Locked Drug Generator in the Liver Sinusoid to Enhance Barrier Penetration and Reduction of Liver Fibrosis
Quanwei Sun, Wenshuo Yang, Zhengwei Song, et al.
Journal of the American Chemical Society (2024)
Closed Access
Programmable Morphology‐Adaptive Peptide Nanoassembly for Enhanced Catalytic Therapy
Xuehao Zhang, Ben‐Li Song, Ningbo Yi, et al.
Advanced Materials (2024)
Closed Access
Developing a Prognostic Model for Primary Biliary Cholangitis Based on a Random Survival Forest Model
Xinyu Fu, Yaqi Song, Lin Jiaying, et al.
International Journal of Medical Sciences (2023) Vol. 21, Iss. 1, pp. 61-69
Open Access | Times Cited: 1
Previous Page - Page 2

Scroll to top